Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Source: SeekingAlpha
2025-12-30 08:57:41 ET
Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [10.1%] ( BBH )....
Read the full article on Seeking Alpha
For further details see:
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Novartis AG
NASDAQ: NVS
NVS Trading
-1.36% G/L:
$143.37 Last:
954,184 Volume:
$144.01 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
